Science Explorer Interactive view Map
Company · Cranbury · United States

Crystal Pharmatech (United States)

crystalpharmatech.comROR OpenAlex
Research works
44
▼ 9% vs 2013–17
Citations
789
18.0 per fractional work
Top-10% rate
19.2%
record average 16.5%
Open access
40%
world 28%

Not ranked overall: Crystal Pharmatech (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.59× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.09× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 4.74× its world share, 1 worksImmunology and Micro…Neuroscience: 3.96× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 11.50× its world share, 1 worksPharmacology, Toxico…Chemistry: 4.44× its world share, 1 worksChemistryEngineering: 0.76× its world share, 2 worksEngineeringEnvironmental Science: 0.16× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.87× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.63× its world share, 0 worksPhysics and AstronomyDentistry: 1.64× its world share, 0 worksDentistryMedicine: 2.10× its world share, 6 worksMedicineNursing: 1.31× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 11.5×. Every wedge is a field page.

Which keywords describe research at Crystal Pharmatech (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Medicinal Chemistry, Chemotherapy, Clinical Trials, Targeted Therapy, Frequency Conversion, ALK Inhibitors, EGFR Mutations and Anticancer Agents.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 31 words, with their numbers
  1. Chemotherapy3▲ 8.6×7 topics
  2. Medicinal Chemistry3▲ 17×7 topics
  3. Epidemiology3▲ 1.48×18 topics
  4. Oxidative Stress2▲ 3.0×9 topics
  5. Clinical Trials2▲ 8.5×5 topics
  6. Targeted Therapy2▲ 23×3 topics
  7. ALK Inhibitors2▲ 74×1 topic
  8. EGFR Mutations2▲ 74×1 topic
  9. Frequency Conversion2▲ 42×3 topics
  10. Anticancer Agents2▲ 15×6 topics
  11. Apoptosis2▲ 9.7×5 topics
  12. Cancer2▲ 2.8×9 topics
  13. Nanoparticles2▲ 2.8×7 topics
  14. Cancer Therapy2▲ 5.2×7 topics
  15. Crystal Growth2▲ 10×4 topics
  16. Inflammation2▲ 1.46×13 topics
  17. Metastasis2▲ 10×3 topics
  18. Synthesis2▲ 5.7×6 topics
  19. Pharmacokinetics1▲ 12×3 topics
  20. Molecular Docking1▲ 19×1 topic
  21. Monoclonal Antibodies1▲ 19×2 topics
  22. Monoclonal Antibody1▲ 39×2 topics
  23. Mutation1▲ 18×3 topics
  24. Therapeutic Antibodies1▲ 21×2 topics
  25. Virtual Screening1▲ 39×1 topic
  26. Biopharmaceuticals1▲ 37×1 topic
  27. Breast Cancer1▲ 8.6×4 topics
  28. Heterocyclic Compounds1▲ 15×3 topics
  29. Protein Aggregation1▲ 32×1 topic
  30. Regulation1▲ 4.1×3 topics
  31. Nonlinear Optics1▲ 14×4 topics

Which research topics does Crystal Pharmatech (United States) publish most on?

By volume in 2022–2025: Cancer-related Molecular Pathways, Gas Sensing Nanomaterials and Sensors, Effects of Radiation Exposure and Neurological Disorders and Treatments.

Cancer-related Molecular…1Cancer-related Molecular Pathways: 1 fractional worksGas Sensing Nanomaterial…1Gas Sensing Nanomaterials and Sensors: 1 fractional worksEffects of Radiation Exp…1Effects of Radiation Exposure: 1 fractional worksNeurological Disorders a…0Neurological Disorders and Treatments: 0 fractional worksNeurological Disease Mechanisms and Treatments: 0 fractional worksSolid State Laser Technologies: 0 fractional worksLung Cancer Treatments a…0Lung Cancer Treatments and Mutations: 0 fractional worksCholinesterase and Neurodegenerative Diseases: 0 fractional worksLaser Design and Applications: 0 fractional worksCancer therapeutics and …0Cancer therapeutics and mechanisms: 0 fractional works
OncologyElectrical and Electronic EngineeringRadiology, Nuclear Medicine and ImagingNeurology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer-related Molecular Pathways Oncology 1 works
  2. 2 Gas Sensing Nanomaterials and Sensors Electrical and Electronic Engineering 1 works
  3. 3 Effects of Radiation Exposure Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Neurological Disorders and Treatments Neurology 0 works
  5. 5 Neurological Disease Mechanisms and Treatments Neurology 0 works
  6. 6 Solid State Laser Technologies Electrical and Electronic Engineering 0 works
  7. 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  8. 8 Cholinesterase and Neurodegenerative Diseases Pharmacology 0 works
  9. 9 Laser Design and Applications Electrical and Electronic Engineering 0 works
  10. 10 Cancer therapeutics and mechanisms Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.7%not open60.3%

World: 28% of research is openly available.

with international co-authors44.2%domestic only55.8%

World: 19% is written across borders.

How has Crystal Pharmatech (United States)'s research output changed?

Output in 2018–2022 was 9% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cranbury

All research institutions in Cranbury

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.